tal diabetic nephropathy [14] .
Conclusions. Despite producing normotension, severe diaWhile the experimental streptozotocin (STZ)-induced betic renal pathology was not prevented by bosentan, sugdiabetic rat develops proteinuria and modest expression gesting dissociation of ET, albuminuria, and hypertension from the structural injury in this diabetic model. The beneficial efof extracellular matrix (ECM), it is not associated with a fects afforded by valsartan therapy strengthen the importance loss of renal function. In contrast, the diabetic transgenic of the local renin-angiotensin system in mediating progressive (mRen-2)27 rats develop severe renal impairment and diabetic renal injury.
histologic injury, which resembles human diabetic nephropathy. In the transgenic (mRen-2)27 rat, the mouse Ren-2 gene is inserted into the genome of a SpragueThe control of systemic and possibly intraglomerular Dawley rat such that overexpression of renin occurs at hypertension is a key factor in the management of diasites of normal physiological expression [15] . This model displays hypertension and develops progressive nephropathy with the induction of STZ diabetes, possibly rat, STZ diabetes results in the rapid onset of renal units intraperitoneally; Ultratard, Novo Nordisk, Denimpairment and severe renal pathology, with features mark) to promote weight gain and to reduce mortality. similar to those observed in advanced human diabetic Experimental procedures adhered to the guidelines of nephropathy. This progressive renal disease is prevented the National Health and Medical Research Council of by ACE inhibitor treatment [16] .
Australia's Code for the Care and Use of Animals for Endothelin (ET), a potent proinflammatory mediator, Scientific Purposes, and were approved by the Bioethics has also been implicated in the progression of various Committee of the University of Melbourne. renal pathologies [17] . ET has been shown to be elevated Renal functional and biochemical studies in the diabetic kidney [18] , and ET antagonists have been reported to reduce growth factor expression and Rats were individually housed in metabolic cages ev-ECM accumulation in glomeruli from diabetic rats ery four weeks and habituated for two to three hours, [18, 19] . Furthermore, ET antagonists ameliorate renal and measurements of fluid intake and urine excretion pathology in several experimental models of kidney disrate were recorded over 24 hours. Animals continued to ease [20, 21] . In the kidney, ET-1 mRNA is reduced by have free access to tap water and standard laboratory ACE inhibition [19] , and in vascular tissue, the effects chow during this period. After 24 hours in metabolic of Ang II infusion are ameliorated by ET antagonism cages, an aliquot of urine (5 mL) was collected from the [22] . Together, these studies suggest a functional interre-24-hour urine sample and stored at Ϫ70ЊC for subselationship between ET, Ang II, and structural injury. quent analysis of urinary electrolytes and albumin conOur current study compares an AT 1 receptor antagocentration. Urinary Na ϩ and K ϩ concentrations and nist with an ET A and ET B receptor antagonist at an equiplasma electrolytes were measured in duplicate using an potent antihypertensive dose to explore the relative automated IL 943 flame photometer (Instrumentation involvement of Ang II and ET in mediating the renal Laboratories, Milan, Italy). functional and structural abnormalities observed in the Albuminuria was determined by a double antibody STZ diabetic Ren-2 rat.
radioimmunoassay, as previously performed in our laboratories [23] . The glomerular filtration rate (GFR) was determined by injecting a single shot of 99 Tc-DTPA into METHODS the tail vein and sampling the blood after 43 minutes, Animals as previously described [24] . Six-week-old female, heterozygous Ren-2 rats, weighing 125 Ϯ 5 g, were randomized to receive either 55
Plasma preparation mg/kg of STZ (Sigma, St. Louis, MO, USA) diluted in Prior to sacrifice, plasma samples (100 L) were col-0.1 mol/L citrate buffer, pH 4.5, or citrate buffer alone lected in heparinized vials (10 U/mL) from the tail vein (nondiabetic) by tail vein injection following an overof conscious rats. The blood samples were centrifuged night fast. Female rats were chosen because they do not at 2000 ϫ g for five minutes at 4ЊC, and the plasma require maintenance antihypertensive therapy. Diabetic supernatant was removed and frozen for later estimaand nondiabetic Ren-2 (N ϭ 6 per group) were treated tions of Na ϩ and K ϩ . with an AT 1 receptor antagonist, valsartan (average dose of 20 mg/kg/day, in drinking water; Novartis, Basel, SwitAnatomical studies zerland), or the ET (ET A and ET B ) receptor antagonist Rats were anesthetized (Nembutal 60 mg/kg body wt bosentan (gavaged dose of 100 mg/kg/day; Roche, Basel, intraperitoneally; Rhone Merieux, Pinkenba, QLD, AusSwitzerland) for 12 weeks post-STZ or vehicle. Treattralia), and the abdominal aorta was cannulated with an ment commenced within 24 hours of STZ injection. All 18-gauge needle. Perfusion-exsanguination commenced rats were housed in a stable environment (maintained at SBP (180 to 220 mm Hg) via the abdominal aorta at 22 Ϯ 1ЊC with a 12-h light-day cycle) and allowed free with 0.1 mol/L phosphate-buffered saline (PBS), pH 7.4 access to tap water and standard rat chow containing (20 to 50 mL), to remove circulating blood, and the 0.25% Na ϩ and 0.76% K ϩ (GR2; Clark-King & Co., inferior vena cava adjacent to the renal vein was simultaGladesville, NSW, Australia). Each week, rats were neously severed, allowing free flow of the perfusate. weighed, and blood glucose (nondiabetic, 4 to 8 mmol/L; After clearance of circulating blood, 4% paraformaldediabetic, 18 to 22 mmol/L) was determined using an hyde in 0.1 mol/L phosphate buffer, pH 7.4, was perfused AMES glucometer (Bayer Diagnostics, Melbourne, Ausfor a further five minutes (100 to 200 mL of fixative) to fix tralia). Every four weeks, SBP was recorded in preheated the tissues [25] . Kidneys were removed from the animal, conscious rats by tail cuff plethysmography. An average decapsulated, and sliced transversely. Kidneys were SBP reading was taken from three consecutive measurepostfixed in the same fixative for two hours, routinely ments to reduce variability (Bunag 1973 ID: 572). Diabetic rats received a daily injection of insulin (2 to 4 processed, embedded in paraffin, and sectioned.
Histopathology mouse and rat renin protein have been previously published by our laboratory [25, 29] . The polyclonal mouse Changes in kidney structure were assessed in a blinded renin protein antibody was raised against pure mouse protocol in at least 25 randomly selected tissue sections submandibular gland renin [25] , and the polyclonal rat from each group studied. Sections were stained with renin protein was raised in rabbits against a fusion proeither Mayer's hematoxylin and eosin (HE) to examine tein that was incorporated into Escherichia coli [29] . cell structure, periodic acid-Schiff stain (PAS) to identify These antisera specifically label juxtaglomerular cells of changes in basement membrane architecture and glycothe kidney, zona glomerulosa cells of the adrenal, and gen deposition, or Masson's modified trichrome to demmacroglial Mü ller cells of the retina. Renin protein antionstrate collagen matrix [26] . sera reveal the presence of both prorenin and partially or fully processed active renin.
Glomerulosclerotic index
From 3 m kidney sections stained with PAS, 150 to
In situ hybridization 200 glomeruli from rats were examined in a masked The 1.4 kb cDNA probe for rat renin (gift of Dr. D.J. protocol. The degree of sclerosis in each glomerulus was Campbell, Melbourne, Australia) was cloned into pGEM subjectively graded on a scale of 0 to 4 by the method 4 (Stratagene, La Jolla, CA, USA) and linearized with of Saito et al: grade 0, normal; grade 1, sclerotic area up Bam HI to produce an antisense riboprobe with T7 RNA to 25% (minimal); grade 2, sclerotic area 25 to 50%
polymerase. The 945 bp cDNA probe for TGF-␤1 (gift (moderate); grade 3, sclerotic area 50 to 75% (moderate of Dr. Qian, Bethesda, MD, USA) and the 600 bp cDNA to severe); and grade 4, sclerotic area 75 to 100% (severe) probe for ␣1(IV) collagen (gift of Dr. R. Timpl, Mar- [27] . Glomerulosclerosis was defined as glomerular basetinsried, Germany) were also cloned into pBluescript ment membrane (GBM) thickening, mesangial hypertro-KSϩ (Stratagene) and linearized with XbaI and HindIII phy, and capillary occlusion. A glomerulosclerotic index to produce antisense riboprobes with T7 RNA polymer-(GSI) was then calculated using the formula:
ase. In situ hybridization was performed on 4 m paraffin sections, which were hybridized with antisense probes
Fi (i) to renin, TGF-␤1, and collagen IV [12] . Tissue sections were dewaxed in histosol, hydrated through graded ethawhere Fi is the percentage of glomeruli in the rat with nol, and immersed in distilled water. Sections were then a given score (i).
washed in 0.1 mol/L PBS, pH 7.4, and hybridized with 33 P-labeled antisense and sense-specific probes (5 ϫ 10 5 Immunohistochemistry cpm/25 L hybridization buffer), which were added to Three micron sections were placed into histosol to hybridization buffer (300 mmol/L NaCl, 10 mmol/L Trisremove the paraffin wax, hydrated in graded ethanol, HCl, pH 7.5, 10 mmol/L Na 2 HPO 4 , pH 6.8, 5 mmol/L and immersed into tap water before being incubated for ethylenediaminetetraacetic acid (EDTA), pH 8.0, 1 ϫ 20 minutes with normal goat serum (NGS) diluted 1:10 Denhardt's solution, 0.8 mg yeast RNA/mL, 50% deionwith 0.1 mol/L PBS, pH 7.4. Sections were then incubated ized formamide, and 10% dextran sulfate), heated to for 18 hours at 4ЊC with specific primary antisera to renin 85ЊC and 25 L added to the sections. Cover slips were protein. Sections incubated with 1:10 NGS instead of the placed on the sections, and the slides were incubated in primary antiserum served as the negative control. After a humidified chamber (50% formamide) at 60ЊC for 14 thorough washing with PBS (3 ϫ 5 min changes), the to 16 hours. Slides were then washed in 2 ϫ standard sections were flooded with a solution of 5% hydrogen saline citrate (SSC; 0.3 mol/L NaCl, 0.33 mol/L Na 3-peroxide, rinsed with PBS (2 ϫ 5 min), and incubated C 6 H 5 O 7 ϩ2H 2 O) containing 50% formamide at 50ЊC to with biotinylated goat antirabbit IgG (Dakopatts, Gloremove the cover slips. The slides were again washed strup, Denmark) diluted 1:200 with PBS. Sections were with 2 ϫ SSC, 50% formamide for a further one hour rinsed with PBS (2 ϫ 5 min) and incubated with an at 55ЊC. Sections were then rinsed three times in RNase avidin-biotin peroxidase complex (Vector, Burlingame, buffer (10 mmol/L Tris-HCl, pH 7.5, 1 mmol/L EDTA, CA, USA) diluted 1:200 with PBS. Following rinsing pH 8.0, 0.5 mol/L NaCl) at 37ЊC and treated with 150 g with PBS (2 ϫ 5 min), sections were incubated with RNase A/mL in RNnase buffer for a further one hour 0.05% diaminobenzidine and 0.05% hydrogen peroxide at 37ЊC and then washed with 2 ϫ SSC at 55ЊC for (Pierce, Rockford, IL, USA) in PBS, pH 7.6, for one 45 minutes. Finally, sections were dehydrated through to three minutes, rinsed in tap water for five minutes, graded ethanol, air dried, and exposed to Kodak X-Omat counterstained in Mayer's hematoxylin, differentiated in Autoradiography film for four days at room temperature. Scott's tap water, dehydrated, cleared, and mounted in Slides were coated with Ilford K5 emulsion (Ilford, 1:1 Depex [28] .
with distilled water), stored with desiccant at room temperature for 21 days, developed in Kodak D19, fixed in The nature and specificities of the antisera raised to group), as previously described [30] .
Values are expressed as means Ϯ SEM; N ϭ 6 rats per group. V, valsartan; B, bosentan; GFR, glomerular filtration rate.
a P Ͻ 0.05 when compared with respective nondiabetic rats Statistics b P Ͻ 0.05 when compared to respective untreated rats Data are expressed as means Ϯ SEM unless otherwise stated. Statistical significance was determined by a twoway analysis of variance (ANOVA) with a Fishers post played the largest increase in urinary electrolyte output hoc comparison. Albuminuria was analyzed using log (P Ͻ 0.05; Table 1 ). transformed data and a represented as geometric means Renal parameters. Diabetes was associated with an ϫ/Ϭ tolerance factors. Analyses were performed using increase in urinary albumin excretion. Bosentan treatStatview II ϩ Graphics package (Abacus Concepts, ment increased albumin excretion further in both nondiBerkeley, CA, USA) on an Apple Macintosh G3 comabetic and diabetic rats, while valsartan treatment was puter (Apple Computer, Inc., Cupertino, CA, USA). A associated with reduced albumin excretion in diabetic P value Ͻ 0.05 was regarded as statistically significant. rats (Table 2 ). The impairment in GFR observed in diabetic Ren-2 rats was attenuated by all treatment regimens, although the GFR was still significantly lower than RESULTS the respective drug-treated nondiabetic rats (Table 2 ).
Renal functional and biochemical studies
Body weight, systolic blood pressure and plasma gluAnatomical studies cose. Diabetic rats had reduced body weight indepenIn the kidney cortex of nondiabetic rats, there was dent of treatment (P Ͻ 0.01). SBP was decreased to a no significant renal pathology (Fig. 1A ). However, in similar level within one week of commencement of either diabetic rats, most glomeruli displayed thickened GBM, valsartan or bosentan in diabetic rats (P Ͻ 0.01; Table mesangial expansion, and capillary occlusion, as well as 1). Plasma glucose was elevated to a similar extent in all efferent arteriole hyalinization and tubular vacuolation diabetic rat groups, independent of treatment (P Ͻ 0.01; (Fig. 1B) . In both nondiabetic and diabetic rats treated Table 1 ).
with valsartan ( Fig. 1 C, D) and nondiabetic rats treated Plasma and urinary electrolytes. In drug-treated diawith bosentan (Fig. 1E) , only minimal evidence of GBM betic rats, plasma K ϩ was increased compared with drugthickening was apparent. Diabetic rats treated with botreated nondiabetic controls (P Ͻ 0.05). Urinary electrosentan (Fig. 1F ) displayed severe glomerulosclerosis and lyte excretion was increased in diabetic rats, irrespective tubulointerstitial disease. In the medulla of nondiabetic and diabetic rats treated of drug treatment. Valsartan-treated diabetic rats dis- with valsartan (Fig. 2 C, D) and nondiabetic rats treated rats treated with either valsartan or bosentan (data not shown) and diabetic rats treated with valsartan displayed with bosentan (Fig. 2E) , there was no evident pathology. However, in diabetic rats (Fig. 2B ) and diabetic rats labeling for renin mRNA (Fig. 3C ) and protein ( Fig.  4C ) in JGA only. Diabetic rats treated with bosentan treated with bosentan (Fig. 2F) , there was florid deposition of collagen matrix, tubular dilation and degeneradisplayed intense labeling for renin mRNA (Fig. 3D) and protein (Fig. 4D ) in both JGA and proximal tubules. tion, and the presence of inflammatory cells.
Renin mRNA and immunohistochemistry
Transforming growth factor-␤1 and collagen IV mRNA
In nondiabetic rats, TGF-␤1 (Fig. 5 A, B) and collagen In nondiabetic rats, some juxtaglomerular apparatuses (JGAs) were positive for renin mRNA (Fig. 3A) or pro-IV (Fig. 6 A, B) mRNA were barely detected in the kidney, while in diabetic rats, TGF-␤1 (Fig. 5 C, D) and tein (Fig. 4A) , whereas with diabetes, most JGAs and proximal tubules displayed intense labeling for renin collagen IV (Fig. 6 C, D) mRNA were increased (Fig.  7) and associated with sclerotic glomeruli and regions of mRNA (Fig. 3B) and protein (Fig. 4B) . Nondiabetic Nondiabetic rats have no evidence of medullary pathology, whereas (B) diabetic rats have dilated tubules, degenerated vasa recta bundles, and the presence of inflammatory cells (arrow), and there appeared to be more collagen (stained blue). In valsartan-treated nondiabetic (C ) and diabetic rats (D) and bosentan-treated nondiabetic rats (E ), there is no evidence of medullary pathology. Bosentan-treated diabetic rats (F ) have dilated tubules, degenerated vasa recta bundles and the presence of inflammatory cells (arrow), and there appears to be more collagen (stained blue) throughout the interstitium (magnification ϫ300). Reproduction of this figure in color was made possible by Novartis Pharmaceuticals, Bern, Switzerland. tubulointerstitial disease. In valsartan-treated nondianificantly lower than in diabetic rats (P Ͻ 0.05; Table betic (not shown) and diabetic rats, the levels of TGF-␤1
3). The GSI in diabetic rats treated with bosentan was (Fig. 5 E, F) and collagen IV (Fig. 6 E, F) mRNA were not significantly reduced when compared with diabetic similar to nondiabetic rats (Fig. 7) . In bosentan-treated rats (Table 3) , but there were fewer severely sclerotic nondiabetic rats, both TGF-␤1 and collagen IV mRNA glomeruli. (data not shown) were similar to nondiabetic rats (Fig.  7) . In diabetic rats treated with bosentan, TGF-␤1 (Fig.  DISCUSSION  5 G, H) , and collagen IV (Fig. 6 G, H) , mRNA was
Blockade of the RAS with AT 1 antagonists or ACE localized to glomeruli and areas of tubulointerstitial disinhibitors has been shown previously to improve glomerease, similar to that seen in diabetic rats (Fig. 7) . ular hemodynamics and structure in human and rodent Glomerulosclerotic index diabetic nephropathy [2, 4, 5, 31, 32]. The present findings provide further evidence for a direct causal relationship Diabetes was associated with an increase in the GSI. The GSI in diabetic rats treated with valsartan was sigbetween the activity of the intrarenal RAS and the pro- gression of diabetic nephropathy. As with ACE inhibipresent study, hypertension in the Ren-2 rat appeared to be partly ET dependent, yet blockade of the ET receptor tion in our previous study [16] , treatment with the AT 1 antagonist valsartan reduced SBP, ameliorated the sefailed to attenuate the diabetic renal pathology. Therefore, it appears that the vasoconstrictor effects of horvere pathology, and improved the renal function of diabetic Ren-2 rats (Table 4) . By contrast, bosentan, almones such as ET and Ang II can be functionally separated from their actions in the microvascular tissues. though normalizing blood pressure and improving GFR, had little or no effect on the florid renal pathology and Indeed, agents such as AT 1 antagonists or ACE inhibitors can confer renoprotective benefits without major was associated with increased albuminuria (Table 4) .
Bosentan reduced SBP to normotensive levels in both effects of systemic blood pressure, as has been observed in studies performed in normotensive diabetic rats [3] . nondiabetic and diabetic Ren-2 rats, suggesting that the hypertension of this Ren-2 strain is ET dependent. These
Despite only a modest reduction in SBP, agents that interrupt the RAS confer renoprotection in diabetes [5] . findings are in accordance with other investigators who have shown that the hypertension in the Ren-2 rat is
The possibility of renoprotection independent of effects on SBP with agents that interrupt the RAS has also probably mediated by locally generated Ang II and ET [33] . This is in accordance with experimental data, which been suggested in a range of clinical studies of diabetic nephropathy [4] . have shown that the chronic pressor properties of infused Ang II in normal rats are blunted by bosentan [34] . In the The finding that bosentan did not reduce renal pathol- ogy in the diabetic Ren-2 contrasts with other reports This may explain the improvement in GFR in diabetic Ren-2 rats treated with bosentan. A discrepancy between of both hemodynamic and pathological benefits with the ET blockade in various forms of renal disease [20, 21] . the effects of ET receptor antagonism on glomerular function and structural injury has also been reported In other models of experimental diabetes, treatment with another nonselective ET antagonist has reduced both in a model of cyclosporine nephrotoxicity [36] . Other investigators have shown a correlation between GFR albuminuria and SBP [21] , whereas in the present study, ET antagonism decreased SBP but increased albuminand occluded glomeruli in diabetes [37, 38] . This improvement in renal function could relate to the known uria. One must be cautious when comparing the two studies since the present studies were performed in transbeneficial effects of bosentan on glomerular and systemic hemodynamics [39] . ET-1 has been reported to increase genic rats that develop renal failure. In the diabetic Ren-2 rat, it is possible that the disease is predominantly intraglomerular pressure with ET blockade lowering glomerular pressure [40] ; however, this is not a universal Ang II dependent, although kidney and plasma Ang II levels actually decrease with diabetes [35] . The results finding, as a study found that ET can reduce intraglomerular pressure, albeit at high doses [41] . ET-1 induces of the present study suggest that local cell-specific autocrine/paracrine mechanisms may be more relevant than mesangial cell contraction [42] , and therefore, ET blockade would be expected to increase the glomerular filtrawhole tissue peptide levels. Indeed, in the present study, there was evidence of a local increase in renin in proximal tion surface area through mesangial cell relaxation. This effect on the glomerular barrier may explain the intubules of diabetic rat kidneys consistent with specific activation of the RAS within the kidney.
creased albuminuria associated with bosentan in the Ren-2 rats, irrespective of the presence of diabetes. Since Although bosentan did not improve the overall GSI, there were significantly fewer severely sclerotic (grades albumin occurs as a result not only of the glomerulus but also tubular factors, one cannot exclude the effects 3 and 4) glomeruli when compared with untreated rats. In both nondiabetic (A and B) and diabetic rats treated with valsartan (E and F), there was minimal gene expression for collagen IV detected. However, in both diabetic (C and D) and diabetic rats treated with bosentan (G and H), there was intense gene expression for collagen IV in the glomerulus (G) and regions of tubulointerstitial injury (magnification ϫ600). 
Abbreviations are: V, valsartan; B, bosentan; GFR, glomerular filtration rate; SBP, systolic blood pressure; JGA, juxtaglomerular cells; PCT, proximal tubules; ND, not detected.
